Medicare's upcoming weight-loss drug program could create major bottlenecks for doctors as millions of seniors seek access to ...
A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...
Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of "priority vouchers" for expedited drug approvals, suggesting that the voucher program ...
Ocular Therapeutix, Inc. OCUL stock is trading higher on Wednesday as the company prepares for its Investor Day, where it ...
The US Food and Drug Administration (FDA) on Tuesday provided updates on two programs negotiated under the Prescription Drug User Fee Act (PDUFA VII) meant to give sponsors an opportunity to engage ...
A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...
WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results